1Equipment and facility
Fairlue to appropriately and regularly clean and disinfect or sterilize equipment located in the ISO 5 area.
Inspection Record
Fayetteville VA Medical Center — FDA 483 Findings
Inspectors Erik W Koester · Syeda N MahazabinThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
2Contamination control
Beta-lactam drugs were produced without providing adequate containment, segregation, and/or cleaning of work surfaces, utensils, and/or personnel to prevent cross-contamination.
3Contamination control
Microbial contamination was present in the.
About this record
Extracted automatically from the document US FDA published on 2026-09-03. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
